Assignee
LIFEARC
GB·10 granted patents·3 pending applications·0 citations·filing 2016–2022
Top patents by PatentIndex Score
13 records- 0168US11718686B2Anti-transglutaminase 2 antibodiesLIFEARC·Filed 2020·Granted Aug 8, 2023·0 cites·12 claims
- 0260US12202903B2Humanised anti-IL17BR antibodyLIFEARC·Filed 2019·Granted Jan 21, 2025·0 cites·21 claims
- 0358US10961319B2Anti-transglutaminase 2 antibodiesLIFEARC·Filed 2018·Granted Mar 30, 2021·0 cites·11 claims
- 0455US11136338B2Fused thiazolopyrimidine derivatives as MNKs inhibitorsLIFEARC·Filed 2020·Granted Oct 5, 2021·0 cites·16 claims
- 0550US2024208934A1Ulk1/2 inhibitors and their use thereofLIFEARC·Filed 2022·Application pending·0 cites
- 0646US10669284B2Fused thiazolopyrimidine derivatives as MNKS inhibitorsLIFEARC·Filed 2016·Granted Jun 2, 2020·0 cites·20 claims
- 0746US2023151069A1Cyclic PeptidesLIFEARC·Filed 2021·Application pending·0 cites
- 0842US11446351B2Composition for treating one or more estrogen related diseasesLIFEARC·Filed 2019·Granted Sep 20, 2022·0 cites·4 claims
- 0940US10961234B2Oxazole derivatives for use in the treatment of cancerLIFEARC·Filed 2017·Granted Mar 30, 2021·0 cites·26 claims
- 1040US10961233B2Oxazole derivatives for use in the treatment of cancerLIFEARC·Filed 2017·Granted Mar 30, 2021·0 cites·19 claims
- 1138US10918645B2Substituted tricyclic heterocyclic compounds and use thereofLIFEARC·Filed 2017·Granted Feb 16, 2021·0 cites·9 claims
- 1238US2020317753A1Humanized Antibodies Against Enterovirus 71LIFEARC·Filed 2017·Application pending·0 cites
- 1333US10604524B2Pyrropyrimidine compounds as MNKs inhibitorsLIFEARC·Filed 2016·Granted Mar 31, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when LIFEARC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →